Nomi Werbeloff, PhD
- 2Articles
- 7.5KReads1
- 2012–2014Active
- 21Collaborators
- 170Citations2
About
Nomi Werbeloff, PhD, has published research focused on schizophrenia and schizoaffective disorders. Their work includes studies on antipsychotic response determinants and clinical trials investigating low-dose d-serine for negative and cognitive symptoms of schizophrenia. Werbeloff has collaborated with colleagues such as Adiel Doron, Alexander Teitelbaum, Ari A. Gershon, Bruce J. Kinon, and Daniel C. Javitt. Their articles appeared in Psychiatrist.com between 2012 and 2014.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
